589 related articles for article (PubMed ID: 27165744)
21. Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.
Stojadinovic A; Ghossein RA; Hoos A; Nissan A; Marshall D; Dudas M; Cordon-Cardo C; Jaques DP; Brennan MF
J Clin Oncol; 2002 Feb; 20(4):941-50. PubMed ID: 11844815
[TBL] [Abstract][Full Text] [Related]
22. Current and emerging therapies for adrenocortical carcinoma--review.
Przytulska J; Rogala N; Bednarek-Tupikowska G
Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
[TBL] [Abstract][Full Text] [Related]
23. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract][Full Text] [Related]
24. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
25. Adrenocortical carcinoma.
Soon PS; Sidhu SB
Cancer Treat Res; 2010; 153():187-210. PubMed ID: 19957226
[No Abstract] [Full Text] [Related]
26. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA; Krishnan Nair HK
Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
[TBL] [Abstract][Full Text] [Related]
27. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
28. Adrenocortical carcinoma - towards genomics guided clinical care.
Crona J; Beuschlein F
Nat Rev Endocrinol; 2019 Sep; 15(9):548-560. PubMed ID: 31147626
[TBL] [Abstract][Full Text] [Related]
29. Establishing a human adrenocortical carcinoma (ACC)-specific gene mutation signature.
Rahane CS; Kutzner A; Heese K
Cancer Genet; 2019 Jan; 230():1-12. PubMed ID: 30477734
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiling in adrenocortical neoplasia.
Assie G; Giordano TJ; Bertherat J
Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
[TBL] [Abstract][Full Text] [Related]
31. Targeted genomic analysis of 364 adrenocortical carcinomas.
Pozdeyev N; Fishbein L; Gay LM; Sokol ES; Hartmaier R; Ross JS; Darabi S; Demeure MJ; Kar A; Foust LJ; Koc K; Bowles DW; Leong S; Wierman ME; Kiseljak-Vassiliades K
Endocr Relat Cancer; 2021 Aug; 28(10):671-681. PubMed ID: 34410225
[TBL] [Abstract][Full Text] [Related]
32. Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
Roy DM; Walsh LA; Desrichard A; Huse JT; Wu W; Gao J; Bose P; Lee W; Chan TA
Cancer Cell; 2016 May; 29(5):737-750. PubMed ID: 27165745
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
34. Advances in understanding the molecular underpinnings of adrenocortical tumors.
Nicolson NG; Man J; Carling T
Curr Opin Oncol; 2018 Jan; 30(1):16-22. PubMed ID: 29028646
[TBL] [Abstract][Full Text] [Related]
35. Adrenocortical Carcinoma Steroid Profiles:
Muzzi JCD; Magno JM; Cardoso MA; de Moura J; Castro MAA; Figueiredo BC
Front Endocrinol (Lausanne); 2021; 12():672319. PubMed ID: 34194394
[TBL] [Abstract][Full Text] [Related]
36. Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
Ragazzon B; Libé R; Assié G; Tissier F; Barreau O; Houdayer C; Perlemoine K; Audebourg A; Clauser E; René-Corail F; Bertagna X; Dousset B; Bertherat J; Groussin L
Eur J Endocrinol; 2014 Mar; 170(3):385-91. PubMed ID: 24347427
[TBL] [Abstract][Full Text] [Related]
37. CCNB2 and AURKA overexpression may cause atypical mitosis in Japanese cortisol-producing adrenocortical carcinoma with TP53 somatic variant.
Ikeya A; Nakashima M; Yamashita M; Kakizawa K; Okawa Y; Saitsu H; Sasaki S; Sasano H; Suda T; Oki Y
PLoS One; 2020; 15(4):e0231665. PubMed ID: 32287321
[TBL] [Abstract][Full Text] [Related]
38. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
39. Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case Series.
Creemers SG; Korpershoek E; Atmodimedjo PN; Dinjens WNM; van Koetsveld PM; Feelders RA; Hofland LJ
J Clin Endocrinol Metab; 2017 Oct; 102(10):3611-3615. PubMed ID: 28973495
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma.
Taza F; Chovanec M; Hahn N; Albany C
Clin Genitourin Cancer; 2017 Oct; 15(5):e893-e895. PubMed ID: 28606737
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
